Page 800 - First Aid for the USMLE Step 1 2020, Thirtieth edition [MedicalBooksVN.com]_Neat

756 INDEX INDEX

Bevacizumab, 122, 442 metabolism, 72–94 Blastomycosis, 151 Blotting procedures, 53
Bezafibrate, 320 molecular, 34 Bleeding, 642 Blown pupil, 541
Bias and study errors, 260–262 nutrition, 65 adenomatous polyps, 387 CN III damage, 541
Bicalutamide, 658 Biochemistry laboratory techniques direct factor Xa inhibitors, 437 saccular aneurysms, 516
Bicarbonate blotting procedures, 53 direct thrombin inhibitors, 435 “Blue babies,” 298
carbon dioxide transport, 670 Cre-lox system, 56 diverticulosis, 383 Blueberry muffin rash
GI secretion, 372 CRISPR/Cas9, 53 essential thrombocythemia, 433 cytomegalovirus, 182
overdose treatment, 233 enzyme-linked immunosorbent glycoprotein IIb/IIIa inhibitors, 438 rubella, 169, 182
pancreatic insufficiency, 381 assay, 54 heparin, 436 Toxoplasma gondii, 182
salicylate toxicity, 248 flow cytometry, 54 inflammatory bowel disease, 382 “Blue bloater,” 674
TCA toxicity, 233, 248 fluorescence in situ hybridization, peptic ulcer disease, 380 “Blue kids,” 299
Biceps brachii muscle 55 thrombolytics, 437 Blue sclerae, 51
Erb palsy, 448 free light chain (FLC) assay, 431 variceal, 371 Blumer shelf, 379
Biceps femoris, 452, 453 gene expression modifications, 56 warfarin, 436 BMPR2 gene, 679
Biceps reflex, 510 karyotyping, 55 Bleeding time, 427 Body compartments, 231
Biceps tendon, 446 microarrays, 54 Bleomycin Body dysmorphic disorder, 563
Bicornuate uterus, 623 molecular cloning, 55 antitumor antibiotics, 439 Boerhaave syndrome, 377
Bicuspid aortic valve polymerase chain reaction, 52 pulmonary fibrosis, 251 Bombesin, 350
aortic dissection and, 303 reverse transcriptase polymerase targets of, 438 Bone cancer, 464
coarctation of aorta and, 299 chain reaction, 52 toxicity, 444 primary bone tumors, 464
heart murmur with, 291 RNA interference, 56 Blepharospasm, 519 Bone cell biology, 458, 459
thoracic aortic aneurysms and, 302 serum protein electrophoresis, 431 Blindness Bone crises, 88
Turner syndrome, 300 Biofilm-producing bacteria, 128 Chlamydia trachomatis, 149 Bone disorders
Bifid ureter, 579 Staphylococcus epidermidis, 135 giant cell arteritis, 314 adult T-cell lymphoma and, 430
Bifurcation external landmarks, 663 Biologic agents neonatal, 142 lab values in, 464
Biguanide drugs, 353 naming conventions for, 254 Onchocerca volvulus, 159 Langerhans cell histiocytosis, 434
Bilaminar disc, 612 Biomarkers Toxocara canis, 159 lytic (“punched out”), 431
Bilateral adenopathy, 676 α-fetoprotein, 491 Blistering skin disorders, 480 osteogenesis imperfecta, 51
Bilateral renal agenesis astrocytes, 493 Blood Bone formation, 458
oligohydramnios and, 641 neurons, 493 chocolate-colored, 666 Bone-in-bone (x-ray), 463
Potter sequence, 578 Biostatistics/epidemiology, 256–262 coagulation and kinin pathways, Bone marrow
pulmonary hypoplasia and, 660 Biotin, 68 412 cytokine stimulation of, 121
Bile, 374 Bipolar disorder, 561 hCG detection in, 633 lymphoid functions of, 96
hereditary hyperbilirubinemias, drug therapy for, 572 oxygen content, 666 suppression, 199
394 lithium for, 574 in placenta, 617 Bone mineral density scan, 462
secretin effect on, 371 Birbeck granules umbilical cord, 618 Bone morphogenetic protein (BMP),
Bile acid resins, 320 Langerhans cell histiocytosis, 434 viscosity of, 668 490
lipid transport and, 92 “Bird’s beak” sign (X-ray), 376 Blood-brain barrier Bones
reabsorption of, 320 Birds (disease vectors), 148, 149 anesthetics, 549 collagen in, 50
synthesis of, 47 Bismuth, 399 astrocytes, 493 cortisol effect on, 336
Bile canaliculus, 367 Bisoprolol, 245 function and mechanism, 496 lytic/blastic metastases, 223
Bile ducts, 367, 368 Bisphosphonates, 462, 486 at hypothalamus, 498 primary bone tumors, 464
Bile salts, 374 esophagitis with, 249 L-DOPA, 549 PTH effect on, 332
in cholelithiasis, 396 naming convention for, 254 Blood flow renal osteodystrophy, 603
Biliary atresia, 393 osteogenesis imperfecta treatment, autoregulation, 297 Borderline personality disorder,
Biliary cholangitis, primary 51 exercise response, 670 565
autoantibody, 115 Bitemporal hemianopia, 542 Blood groups, 405 Bordetella pertussis, 143
Biliary cirrhosis, 389, 393 craniopharyngioma, 528 Blood-nerve permeability barrier, 495 culture requirements, 126
cystic fibrosis, 60 hypopituitarism, 339 Blood pH exotoxin production, 132
Biliary colic, 396 optic chiasm compression, 516 diuretic effects on, 609 macrolides, 193
Biliary structures, 368 Bitot spots, 66 Blood pressure vaccines, 143
Biliary tract disease, 395 Bivalirudin, 435 angiotensin II effects, 588 Bordet-Gengou agar, 126
Clonorchis sinensis, 161 BK virus, 164 antianginal therapy, 319 Borrelia burgdorferi
gallstones, 368 Black eschar, 137 cortisol effect on, 336 animal transmission, 149
hyperbilirubinemia with, 393 Black lung disease, 677 fenoldopam and, 318 coinfection with, 157
Biliary tract infections Bladder, 160 renal disorders and, 591 facial nerve palsy, 186
Enterococci, 137 bethanechol effect on, 240 sympathomimetic effect on, 243 Lyme disease, 146
Bilirubin, 375 BPH and, 654 Blood-testis barrier, 628 tetracyclines, 192
bile, 374 development of, 618 Blood transfusions, 429 Borrelia recurrentis
cholelithiasis, 396 exstrophy, 624 reactions, 114 animal transmission, 149
hereditary hyperbilirubinemias, outlet obstruction, 579 therapy, 429 vectors, 161
394 placenta percreta invasion, 640 Blood vessels Borrelia spp, 146
liver marker, 390 spasm treatment, 241 collagen in, 50 Bortezomib, 443
toxic shock syndrome, 135 urachus, 618 Ehlers-Danlos syndrome, 50 Bosentan, 686
Bimatoprost, 552 urgency in cystitis, 241 hereditary hemorrhagic Botulinum toxin
Bimodal distribution, 262 Bladder cancer telangiectasia, 316 lysogenic transduction, 130
Binge-eating disorder, 567, 575 cisplatin/carboplatin for, 442 Blood volume passive antibodies for, 110
Binge-eating/purging, anorexia hematuria with, 594 atrial natriuretic peptide release, symptoms of, 138
nervosa, 567 hypercalcemia and, 228 296 toxin effects, 132
Bioavailability, 231 Schistosoma haematobium, 161 regulation, 588 Bovine spongiform encephalopathy
area under the curve from, 231 “Blast crisis,” 433 Bloody diarrhea, 179 (BSE), 178
Biochemistry Blastocyst implantation, 612 Campylobacter jejuni, 145, 149 Bowel stenosis, 383
cellular, 46–52 Blastomyces spp Shigella, 144 Bowen disease, 651
genetics, 56 amphotericin B, 199 ulcerative colitis, 382 Bowenoid papulosis, 651
laboratory techniques, 52–94 itraconazole, 199 Bloody stool, 366 Bow legs (genu varum), 463

FAS1_2019_21_Index_749-806.indd 756 11/21/19 12:27 PM